Table 3. Distribution of mm-SW at... | American Society of Hematology

Table 3.

Distribution of mm-SW at different disease reevaluation time points in CD371^pos BCP-ALL

	Total		Screening cohort		Validation cohort		P value
	n	%	n	%	n	%	P value
Total CD371^pos at diagnosis	157		73	46.5	84	53.5
SW on day 8							.217
Yes	42	65.6	26	60.5	16	76.2
No	22	34.4	17	39.5	5	23.8
NA	93		30		63
SW on day 15							.265
Yes	100	65.4	51	69.9	49	61.3
No	53	34.6	22	30.1	31	38.7
NA	4		0		4
SW on day 33							.317
Yes	4	5.6	1	2.5	3	9.4
No	68	94.4	39	97.5	29	90.6
NA	85		33		52
SW on day 78
Yes	0	0.0	0	0.0	0	0.0
No	86	100.0	54	100.0	32	100.0
NA	71		19		52

	Total		Screening cohort		Validation cohort		P value
	n	%	n	%	n	%	P value
Total CD371^pos at diagnosis	157		73	46.5	84	53.5
SW on day 8							.217
Yes	42	65.6	26	60.5	16	76.2
No	22	34.4	17	39.5	5	23.8
NA	93		30		63
SW on day 15							.265
Yes	100	65.4	51	69.9	49	61.3
No	53	34.6	22	30.1	31	38.7
NA	4		0		4
SW on day 33							.317
Yes	4	5.6	1	2.5	3	9.4
No	68	94.4	39	97.5	29	90.6
NA	85		33		52
SW on day 78
Yes	0	0.0	0	0.0	0	0.0
No	86	100.0	54	100.0	32	100.0
NA	71		19		52

NA, not available.